RGA:NYSEReinsurance Group of America, Incorporated Analysis
Data as of 2026-05-24 - not real-time
$214.04
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
RGA is trading in a bullish technical environment, with the short‑term moving average comfortably above the longer‑term average and the MACD line sitting above its signal, signaling upward momentum. The RSI sits in a neutral zone, suggesting room for further upside without immediate overbought pressure, while volume trends are tapering, indicating a cautious but stable buying interest. Fundamentals reinforce the technical picture: earnings have accelerated across regions, the company posted a strong first‑quarter performance, and management highlighted disciplined capital deployment. The dividend payout remains modest relative to earnings, supporting sustainability and appealing income‑focused investors.
Valuation metrics point to a compelling entry point: the price‑to‑earnings multiple sits well below the industry norm, and the discounted cash‑flow model suggests a significant upside potential. Revenue growth remains robust, and cash generation comfortably covers debt obligations, further lowering financial risk. Combined, these factors make RGA an attractive candidate for investors seeking a blend of growth and defensive qualities.
Valuation metrics point to a compelling entry point: the price‑to‑earnings multiple sits well below the industry norm, and the discounted cash‑flow model suggests a significant upside potential. Revenue growth remains robust, and cash generation comfortably covers debt obligations, further lowering financial risk. Combined, these factors make RGA an attractive candidate for investors seeking a blend of growth and defensive qualities.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical indicators (SMA crossover, MACD bullish)
- Strong quarterly earnings beat
- Modest dividend payout supporting cash flow
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth outpacing peers
- Undervalued valuation relative to earnings and industry
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Diversified global reinsurance platform
- Consistent free cash flow generation
- Low beta and defensive sector positioning
Key Metrics & Analysis
Financial Health
Revenue Growth23.50%
Profit Margin4.92%
P/E Ratio11.6
ROE9.90%
ROA0.85%
Debt/Equity45.61
P/B Ratio1.1
Op. Cash Flow$5.5B
Free Cash Flow$4.8B
Industry P/E16.8
Technical Analysis
TrendBullish
RSI55.4
Support$204.28
Resistance$221.90
MA 20$211.39
MA 50$207.90
MA 200$199.98
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$2,461.45
Target Price$250.56
Upside/Downside17.06%
GradeUndervalued
TypeGrowth
Dividend Yield1.74%
Risk Assessment
Beta0.68
Volatility17.45%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.